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Mutation of a nicotinic acetylcholine receptor b
subunit is associated with resistance to
neonicotinoid insecticides in the aphid Myzus
persicae
Chris Bass1*†, Alin M Puinean1†, Melanie Andrews2, Penny Cutler3, Miriam Daniels3, Jan Elias2, Verity Laura Paul2,
Andrew J Crossthwaite3, Ian Denholm1, Linda M Field1, Stephen P Foster1, Rob Lind3, Martin S Williamson1 and
Russell Slater2
Abstract
Background: Myzus persicae is a globally important aphid pest with a history of developing resistance to
insecticides. Unusually, neonicotinoids have remained highly effective as control agents despite nearly two decades
of steadily increasing use. In this study, a clone of M. persicae collected from southern France was found, for the
first time, to exhibit sufficiently strong resistance to result in loss of the field effectiveness of neonicotinoids.
Results: Bioassays, metabolism and gene expression studies implied the presence of two resistance mechanisms in
the resistant clone, one based on enhanced detoxification by cytochrome P450 monooxygenases, and another
unaffected by a synergist that inhibits detoxifying enzymes. Binding of radiolabeled imidacloprid (a neonicotinoid)
to whole body membrane preparations showed that the high affinity [3H]-imidacloprid binding site present in
susceptible M. persicae is lost in the resistant clone and the remaining lower affinity site is altered compared to
susceptible clones. This confers a significant overall reduction in binding affinity to the neonicotinoid target: the
nicotinic acetylcholine receptor (nAChR). Comparison of the nucleotide sequence of six nAChR subunit (Mpa1-5
and Mpb1) genes from resistant and susceptible aphid clones revealed a single point mutation in the loop D
region of the nAChR b1 subunit of the resistant clone, causing an arginine to threonine substitution (R81T).
Conclusion: Previous studies have shown that the amino acid at this position within loop D is a key determinant
of neonicotinoid binding to nAChRs and this amino acid change confers a vertebrate-like character to the insect
nAChR receptor and results in reduced sensitivity to neonicotinoids. The discovery of the mutation at this position
and its association with the reduced affinity of the nAChR for imidacloprid is the first example of field-evolved
target-site resistance to neonicotinoid insecticides and also provides further validation of exisiting models of
neonicotinoid binding and selectivity for insect nAChRs.
Background
The peach-potato aphid, Myzus persicae is a globally
important pest of a broad range of arable and horticul-
tural crops principally due to its ability to transmit
more than 100 plant viruses [1]. Its control relies almost
exclusively on the application of insecticides and, as a
result, this species has developed multiple resistance to
many chemical classes including organophosphates, car-
bamates and pyrethroids [2]. The molecular mechanisms
of resistance to insecticides in M. persicae include over-
production of detoxifying carboxylesterases (E4 or FE4)
which confers resistance primarily to organophosphates,
and two forms of target-site resistance involving muta-
tion of the acetylcholinesterase protein, (modified acetyl-
cholinesterase, MACE) giving insensitivity to dimethyl
carbamates, and of the voltage-gated sodium channel
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(knockdown resistance, kdr) giving resistance to pyre-
throids [2]. Neonicotinoids such as imidacloprid, thia-
methoxam, clothianidin and acetamiprid are unaffected
by these mechanisms and are currently the main means
of control. Despite two decades of steadily increasing
use neonicotinoids have proved remarkably resilient to
the development of resistance and have remained highly
effective against M. persicae. Samples of M. persicae
with reduced susceptibility to neonicotinoid compounds
(10-40 fold resistance) have been found in Europe, the
USA and Japan [3-5]. However, at present the levels of
resistance described have limited practical significance
as they are insufficient to impair the field effectiveness
of these insecticides [3,5].
Recently, biochemical and genomic approaches were
used to investigate neonicotinoid resistance in a M. persi-
cae clone from Greece showing ~40 fold resistance to neo-
nicotinoids [6,7]. Resistance was associated with multiple
duplications of a single P450 gene (CYP6CY3), with resis-
tant aphids carrying ~18 copies of the gene compared to
the two copies found in susceptible aphids. However,
ligand-binding and sequencing studies provided no evi-
dence that structural modification of the nicotinic acetyl-
choline receptor (nAChR; the neonicotinoid target site)
contributed to resistance in this clone. Although aphids
have continued to be effectively controlled by neonicoti-
noids, resistance is a significant problem in other insect
species including the Colorado potato beetle (Leptinotarsa
decemlineata), the brown planthopper (Nilaparvata
lugens) and the tobacco whitefly (Bemisia tabaci) [5]. As
found for M. persicae, overexpression of one or more
P450s appears to be the primary mechanism of neonicoti-
noid resistance in insect pests [5,8]. The only alternative
mechanism described to date was modification of the tar-
get-site in a laboratory-selected strain of N. lugens, when
resistance was associated with a point mutation in two
nAChR alpha subunits (Nla1 and Nla3) [9]. However,
resistance in field populations of N. lugens appears to
occur exclusively via P450-mediated detoxification [10,11]
and, to date, no case of target-site insensitivity to neonico-
tinoids has been described in individuals of any insect pest
collected directly from the field.
The selectivity of neonicotinoids for insects is thought
to be due, at least in part, to their high affinity for insect
nAChRs [12]. Nicotinic receptors are ligand-gated ion
channels made up of five subunits arranged in combina-
tions from a family of different subunit subtypes [13].
Insect genomes sequenced to date have contained around
ten genes encoding alternative nAChR subunit subtypes
and six genes have been characterised in M. persicae [14].
We report here, for the first time, a clone of M. persi-
cae with extremely potent resistance to neonicotinoids
that compromises the field effectiveness of members of
this insecticide class. We provide evidence that both
P450-mediated detoxification of neonicotinoids and tar-
get-site insensitivity confer the resistance phenotype.
This is the first example of field-evolved target-site resis-
tance to neonicotinoid insecticides.
Results
Topical bioassays
A clone of M. persicae (FRC) originating from peach
orchards in Southern France exhibited potent resistance
to imidacloprid and thiamethoxam when compared to a
susceptible clone (4106A) in insecticide bioassays using
two different methods of topical application (Table 1).
Indeed, using a micro-application method (applying
insecticide directly to the dorsal surface of individual
aphids), resistance was immeasurable due to insufficient
mortality at the highest concentration that could be
applied. A comparison of the resistance profile of FRC
with 5191A (previously the most neonicotinoid-resistant
M. persicae clone described) using the same bioassay
method (Table 1) highlights the significantly enhanced
level of resistance exhibited by FRC. Spray application
bioassays, which combine direct contact with insecticide
and subsequent exposure to residues on leaves, gave
measurable resistance factors of 1679- and 225-fold to
imidacloprid and thiamethoxam respectively. In the
micro-application assays there was evidence that pre-
treatment with the metabolic enzyme inhibitor piperonyl
butoxide (PBO) synergised the effect of thiamethoxam
(Table 1) although high levels of resistance remained (RF
of 800). The effect of pre-treatment with PBO was more
evident in spray application bioassays, with resistance
factors reduced to 234-fold for imidacloprid and 26-fold
for thiamethoxam (Table 1).
Imidacloprid metabolism
The metabolism of imidacloprid (1-(6-chloro-3-pyridyl-
methyl)-N-nitroimidazolidin-2-ylideneamine) has been
well characterised in mammals, plants, soil and some
insect species [15]. Whilst a range of primary metabolites
have been identified, the major metabolic pathway identi-
fied in many species is hydroxylation and desaturation of
the imidazolidine ring to form the hydroxy and olefin
metabolites [15]. Initial LC-MS/MS analysis investigating
ten selected metabolites (Additional file 1) revealed that
the 4/5-hydroxy metabolite was the only metabolite
detected in aphids treated with a topical application of
imidacloprid. Therefore, subsequent analysis focused on
parent imidacloprid and the 4/5-hydroxy metabolite to
determine whether there were differences in imidacloprid
metabolism between FRC and 4106A.
LC-MS/MS analysis did reveal significant differences in
imidacloprid metabolism between FRC and 4106A. For
4106A, recovery of imidacloprid increased in a time-
dependent manner over the course of the experiment,
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reaching a maximum of 0.43 (± 0.06) ng mg-1 of aphids
after 24 h (Figure 1A), suggesting that the rate of imida-
cloprid uptake across the cuticle was greater than the
rate of imidacloprid metabolism and excretion. In con-
trast, for FRC the recovery of imidacloprid decreased in a
time-dependent manner, reaching a minimum of 0.19
(± 0.05) ng mg-1 of aphids after 24 h (Figure 1A). In
terms of metabolite production, in clone 4106A recovery
of the 4/5-hydroxy metabolite was variable, often being
below the limit of detection and/or limit of quantifica-
tion. However, in the FRC clone, this metabolite was
more consistently detected and was produced in a time-
dependant manner, reaching a maximum (21.24 (± 5.80)
relative peak area/mg of aphid) after 24 h (see Figure 1B).
Although the 4/5-hydroxy metabolite has been shown to
possess some insecticidal activity, its specific activity at
the nAChR is weaker than imidacloprid [16].
Microarray Analysis
Microarray analysis identified 571 genes significantly dif-
ferentially transcribed between FRC and 4106A. The full
list of these genes along with Log2, calculated fold-
change values and a description based on the closest
BLAST hit is given in Additional file 2. 349 genes (213
of unknown function) had elevated expression in FRC
and 222 (143 of unknown function) were under-tran-
scribed in this clone relative to 4106A. Of the 136 over-
expressed genes with a known function, 26 were poten-
tial candidates for being involved in insecticide resis-
tance and are listed in Table 2. These included genes
encoding cytochrome P450s, carboxylesterase E4/FE4
and a glutathione-S-transferase.
Table 1 Response of Myzus persicae clones 4106A (susceptible), 5191A (moderately resistant) and FRC (highly
resistant) to imidacloprid and thiamethoxam using two bioassay methods, with and without pretreatment with
piperonyl butoxide (PBO)
Micro-application Spray application
Treatment Clone LC50
1(mg l-1) 95%CL RF2 LC50 (mg l
-1) 95% CL RF2
Imidacloprid 4106A 0.99 0.9-1.4 0.14 0.11-0.17 -
5191A 31.1 7-69.7 31.4 - - -
FRC 28% at 1000 mg l-1 n/c n/c 235.02 142.33-476.29 1679
Imidacloprid+PBO 4106A 0.1 0.07-0.15 0.03 0.01-0.10 -
5191A 1.55 0.56-2.55 14.9 - - -
FRC 30% at 1000 mg l-1 n/c n/c 7.03 1.77-37.91 234
Thiamethoxam 4106A 0.64 0.54-0.79 0.48 0.42-0.55 -
5191A 19.7 14.87-25.74 30.8 - - -
FRC 10% at 1000 mg l-1 n/c n/c 107.84 69.52-185.36 225
Thiamethoxam+PBO 4106A 0.27 0.18-0.32 0.19 0.09-0.41 -
5191A 1.06 0.77-1.45 3.93 - - -
FRC 216 110.25-483.48 800 4.86 2.03-14.91 26
5191A was only tested by micro-application of insecticide.
1Calculated concentration to kill 50% of individuals. If unobtainable, % mortality at the highest concentration applied.
2 Resistance factor (LC50 resistant/LC50 susceptible). n/c = not calculable.
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Figure 1 Internal concentrations of A) imidacloprid and B) 4/5-
hydroxy-imidacloprid from aphids treated with a topical
application of imidacloprid. Graphs represent mean recovery of A)
imidacloprid (ng mg-1 of aphids) and B) 4/5-hydroxy imidacloprid
(relative peak area mg-1 of aphids) ± SE (n = 3 pooled samples of
250 aphids). * Denotes a statistically significant difference between
4106A and FRC clones with p < 0.05 (1-tailed Student’s t-test).
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Five EST sequences encoding carboxylesterase FE4 and
the closely related variant E4 were identified as over-
expressed in the resistant clone. However the level of
expression was variable (ranging from 42-291-fold)
probably because as reported previously only one of the
five ESTs (contig 3118) is a perfect match with E4/FE4
[7]. It is likely that the fold-change indicated by hybridi-
sation to the probe designed on contig 3118 is the most
accurate and this showed a ~290-fold over-expression.
Five EST sequences (Table 2) corresponding to the
M. persicae cytochrome P450 gene CYP6CY3 showed ele-
vated expression in the FRC clone (9-14-fold). Overexpres-
sion of this gene was reported previously to be associated
with moderate levels (25-40-fold) of resistance to neonico-
tinoids in the M. persicae clone 5191A (see introduction).
Eleven additional EST sequences encoding P450s were also
overexpressed in the FRC clone but the changes observed
were relatively low (2-4-fold). Analyses of these sequences
indicated that the 11 ESTs probably correspond to seven
cytochrome P450 genes. Two are most similar in sequence
to the Acyrthosiphon pisum P450 genes CYP380C3 (repre-
sented by ESTs 2519 and 82930), and CYP380C5v1 (repre-
sented by ESTs 27229 and 1504) that belong to the CYP4
clade. The remaining five genes are most similar to the A.
pisum P450 genes, CYP6CY2 (represented by EST 27444),
CYP6CY4 (represented by EST 74544), CYP6CY7 (repre-
sented by ESTs 26873, 643 and DW362118), CYP6CY8
(represented by EST 1501) and CYP6CY17 (represented by
EST 4886) belonging to the CYP3 clade. Finally, a single
GST gene most similar in sequence to other insect GSTs
of the sigma class showed a moderate (~3-fold) increase in
expression in FRC compared to 4106A.
Among the 79 genes of known function that were
under-transcribed in FRC relative to 4106A, a limited
number of detoxification genes were identified (see
Additional file 2). These included four sequences
Table 2 Selected genes identified by microarray as significantly differentially transcribed between the insecticide
resistant M. persicae clone (FRC) and the susceptible clone (4106A)
Description Mean
Log2
Fold
change
Parent
sequence ID
ref|X74555.1| M.persicae mRNA for esterase FE4 8.18 290.98 contig3118
ref|X74555.1| M.persicae mRNA for esterase FE4 6.99 127.91 454Myzus_30192
ref|X74554| M.persicae mRNA for esterase E4 5.95 62.07 contig720
ref|X74555.1| M.persicae mRNA for esterase FE4 5.78 55.25 contig9215
ref|X74554| M.persicae mRNA for esterase E4 5.44 43.60 contig720
ref|X74554| M.persicae mRNA for esterase E4 5.40 42.39 contig4586
ref|HM009309|Myzus persicae cytochrome P450 (CYP6CY3) mRNA, complete cds 3.76 13.60 contig749
ref|HM009309|Myzus persicae cytochrome P450 (CYP6CY3) mRNA, complete cds 3.72 13.26 contig749
ref|HM009309|Myzus persicae cytochrome P450 (CYP6CY3) mRNA, complete cds 3.46 11.01 contig497
ref|HM009309|Myzus persicae cytochrome P450 (CYP6CY3) mRNA, complete cds 3.37 10.40 contig497
ref|HM009309|Myzus persicae cytochrome P450 (CYP6CY3) mRNA, complete cds 3.34 10.18 454Myzus_77428
ref|HM009309|Myzus persicae cytochrome P450 (CYP6CY3) mRNA, complete cds 3.19 9.15 contig5173
ref|XM_001952692.1| PREDICTED: Acyrthosiphon pisum similar to cytochrome P450 (LOC100163313) 2.12 4.36 454Myzus_27444
ref|XM_001946504.1| PREDICTED: Acyrthosiphon pisum similar to glutathione S-transferase-like protein,
transcript variant 1 (LOC100168850)
1.55 2.94 contig3513
ref|XM_001947885.1| PREDICTED: Acyrthosiphon pisum similar to cytochrome P450 CYP6AX1 protein
(LOC100160895)
1.49 2.83 454Myzus_26873
ref|XP_001944530.1| PREDICTED: similar to cytochrome P450 4A7 [Acyrthosiphon pisum] 1.47 2.78 contig2519
ref|XM_001944991.1| PREDICTED: Acyrthosiphon pisum similar to cytochrome P450 4A7 (LOC100162710) 1.43 2.70 454Myzus_27229
ref|XM_001944991.1| PREDICTED: Acyrthosiphon pisum similar to cytochrome P450 4A7 1.41 2.67 contig1504
ref|XM_001944495.1| PREDICTED: Acyrthosiphon pisum similar to cytochrome P450 4A7 (LOC100158738) 1.40 2.65 454Myzus_82930
ref|XM_001944991.1| PREDICTED: Acyrthosiphon pisum similar to cytochrome P450 4A7 1.30 2.55 contig1504
ref|XM_001947885.1| PREDICTED: Acyrthosiphon pisum similar to cytochrome P450 CYP6AX1 protein
(LOC100160895)
1.34 2.55 contig643
ref|XM_001947885.1| PREDICTED: Acyrthosiphon pisum similar to cytochrome P450 CYP6AX1 protein
(LOC100160895)
1.33 2.52 DW362118.1
ref|XM_001947885.1| PREDICTED: Acyrthosiphon pisum similar to cytochrome P450 CYP6AX1 protein
(LOC100160895)
1.26 2.40 contig643
ref|XM_001948546.1| PREDICTED: Acyrthosiphon pisum similar to cytochrome P450 CYP6AX1 protein 1.23 2.35 454Myzus_74544
ref|XM_001948386.1| PREDICTED: Acyrthosiphon pisum similar to cytochrome P450 CYP6AX1 protein 1.18 2.28 contig4886
ref|NM_001163211.1| Acyrthosiphon pisum cytochrome P450 protein 1.07 2.10 contig1501
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encoding GSTs with a negative fold change of -2 to -10,
two sequences encoding CYP6-type cytochrome P450s
and one sequence encoding a CYP4-type P450 with a
fold change of -2 to -3.5.
Real-time quantitative PCR was used to validate
microarray results by examining the expression profile
of CYP6CY3 and the seven additional over-expressed
P450 genes. Expression was compared simultaneously
between FRC, 4106A and 5191A (Additional file 3). In
all cases the increased transcription of the genes was
confirmed (apart from the P450 gene encoded by EST
27444 which could not be amplified by PCR despite
repeated attempts using several alternative primer pairs).
As shown in Additional file 3 the CYP6CY3 gene was
over-transcribed in FRC 28-fold compared to 4106A but
this was not significantly different to the level of expres-
sion in 5191A. Overexpression of this gene in 5191A
was previously shown to be due, in part, to a 9-fold
amplification of the structural gene [7]. Quantitative
PCR was therefore used to determine CYP6CY3 gene
copy number in the FRC clone using genomic DNA as
template and normalising data to the para gene present
in two copies in diploid insect genomes. FRC showed a
fold change in copy number of 8.3 +/- 0.52 comparable
to that in 5191A. Of the remaining P450 genes, five
(two CYP4 and three CYP6-type) were found to be
overexpressed in FRC compared to both 4106A and
5191A although the fold-changes observed were low (2-
3-fold). The exception was the P450 gene represented
by EST 74544 which showed a higher (7-fold) level of
overexpression. However, this gene was also overex-
pressed at a similar level in 5191A suggesting it is not
involved in the enhanced resistance phenotype displayed
by FRC.
Radioligand binding assays
Radioligand binding assays of [3H]-imidacloprid to aphid
membrane preparations revealed substantial differences
in the nature of imidacloprid binding between FRC and
4106A. As described previously, [3H]-imidacloprid recog-
nised two sites in the susceptible 4106A clone, one of
very high (sub nM) affinity and a second lower (~nM)
affinity site [17] (Figure 2A and 2B, Table 3). In the FRC
clone the dual nature of [3H]-imidacloprid binding
was absent with only a single lower affinity binding site
present, as demonstrated by a Hill value close to unity
(Figure 2, Table 3), resulting in an overall reduction in
binding affinity. In addition, this single binding site was
present at far greater concentrations than that observed
for the [3H]-imidacloprid binding sites in 4106A indi-
cated by the substantially increased Bmax value in the
FRC clone. The Kd values recorded in this study for wild-
type M. persicae differ somewhat from those recorded
previously (0.14 ± 0.01 and 12.58 ± 1.83 nM) [17],
however, there are some significant experimental differ-
ences between the two studies. Firstly, in this study larger
final incubation volumes (1 ml) were used to avoid ligand
depletion at very low concentrations of added [3H]-imi-
dacloprid. Secondly, two different wild-type strains were
used, US1L by Lind et al and 4106A in this study.
Sequence analysis of M. persicae nAChR subunit genes
The N-terminal region of the M. persicae nAChR a1-a5
and b1 subunits, encompassing the conserved domains
(loops A to F) that comprise the acetylcholine and neo-
nicotinoid binding site were amplified by PCR from
FRC, 5191A, and 4106A and examined by nucleotide
sequencing. Although a limited number of silent SNPs
were detected in the nucleotide sequence of the nAChR
Figure 2 (A) Comparative saturation isotherms of 3H-IMD
binding in crude membranes from 4106A and FRC Myzus
persicae clones, using MLA as the non-specific ligand (n = 3
+/-SD). (B) Scatchard plot of data derived from (A) demonstrating
the presence of multiple binding sites in 4106A but only a single
binding site in FRC.
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a1-a5 subunits, no non-synonymous changes were
observed and the deduced amino acid sequence in the
region studied was identical between all clones. In con-
trast, when the sequence of the Mpb1 subunit was com-
pared a non-synonymous SNP was observed exclusive to
FRC that causes an amino acid replacement of arginine
(AGA) to threonine (ACA) at amino acid position 81
within loop D, a predicted agonist binding site of
nAChR b subunits (Table 4). Additional sequencing of
RT-PCR products derived from RNA extracted from
individuals confirmed that this mutation is homozygous
in FRC.
Discussion
The neonicotinoids are the fastest growing class of
insecticides in the global crop protection market with
annual worldwide sales of over $1.5 billion [18]. They
have remained effective against M. persicae because they
circumvent the resistance mechanisms that have evolved
to other insecticide classes, and have so far not been
compromised by the evolution of novel mechanisms. In
this study we have characterised a field-derived clone
(FRC) of M. persicae exhibiting sufficiently high levels of
neonicotinoid resistance to impair field performance of
these insecticides. The involvement of P450-mediated
detoxification in resistance was initially implicated by
the use of PBO, an inhibitor of metabolic enzymes
including P450s, which was found to alter the phenotype
of the resistant clone. Further evidence was provided by
LC-MS/MS analysis of imidacloprid metabolism, which
demonstrated that the 4/5-hydroxy-imidacloprid meta-
bolite, a product of phase I reactions catalysed by micro-
somal P450s [15], was produced at higher levels in FRC
than the susceptible clone (4106A). Microarray and
quantitative real-time PCR analyses showed that a cyto-
chrome P450 gene CYP6CY3 was overexpressed in the
FRC clone 28-fold and this was due in part to an eight-
fold amplification of the structural gene. Amplification
of this gene has been reported previously for M. persicae
where it was associated with moderate (25-40-fold)
resistance to neonicotinoids in a clone from Greece
(5191A) [7]. However, the levels of expression of this
gene in FRC and 5191A were not significantly different
and are therefore unlikely to explain the significantly
enhanced levels of resistance seen in the FRC clone. A
small number of additional P450 genes were found to
be overexpressed in FRC compared to both 4106A and
5191A. However, the level of overexpression was rela-
tively low (2-3) fold and while it is possible the proteins
encoded by these genes may play some role in resistance
it is unlikely their overexpression explains the signifi-
cantly enhanced level of resistance exhibited by FRC
compared to 5191A. The gene encoding carboxylester-
ase FE4 was also highly overexpressed (~290-fold) in
FRC but this is an established mechanism of resistance
to other insecticides that has been shown to have no
effect on neonicotinoids [7,19].
Bioassays also provided strong evidence of an addi-
tional major mechanism(s) in resistance with a signifi-
cant resistance factor remaining in the FRC clone to
both thiamethoxam and imidacloprid after synergism by
PBO. To investigate the possibility of target-site insensi-
tivity in resistance, the binding of [3H]-imidacloprid to
membrane preparations of FRC and 4106A was com-
pared. Previous binding studies with a range of insect
species have demonstrated that while all insect species
examined have a binding site for imidacloprid, Hemi-
pteran insects including M. persicae have two sites, one
of very high affinity and a second of lower affinity
[17,20]. This may account for the enhanced efficacy of
Table 3 [3H]-imidacloprid saturable binding to membrane preparations of the FRC and 4106A M. persicae clones using
methyllycaconitine as the non-specific ligand (n = 3 +/-SD)
Clone High affinity Low affinity
kd (nM) Bmax (fmols/mg) kd (nM) Bmax (fmols/mg) Hill value (nH)
FRC - - 4.14 (± 0.39) 2016 (± 70.5) 1 (± 0.005)
4106A 0.083 (± 0.0085) 100 (± 55) 1.7 (± 0.65) 298 (± 48) 0.78 (± 0.072)
Table 4 Alignment of amino acid sequence in loop D of
the agonist binding site of vertebrate and insect
nicotinic acetylcholine receptors
Amino Acid Number of Myzus persicae b1
Subunit
Species 77 78 79 80 81 82 83 84 85 86 87
Homo sapiens b2 N V W L T Q E W E D Y
Gallus gallus b2 N V W L T Q E W E D Y
Rattus norvegicus b2 N V W L T Q E W E D Y
Drosophila
melanogaster b1
C V W L R L V W Y D Y
Anopheles gambiae b1 N V W L R L V W S D Y
Bemisia tabaci b1 N V W L R L V W N D Y
Locusta migratoria b1 N V W L R L V W N D Y
Heliothis virescens b1 N V W L R L V W M D Y
Ctenocephalides felis b1 N V W L R L V W S D Y
Myzus persicae 4106A
b1
N V W L R L V W R D Y
Myzus persicae 5191A
b1
N V W L R L V W R D Y
Myzus persicae FRC b1 N V W L T L V W R D Y
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imidacloprid against sap-feeding insects such as aphids,
leafhoppers and planthoppers [17]. In a previous study
no difference in the binding of [3H]-imidacloprid to
membrane preparations from 5191A and 4106A was
observed [7]. However, in this study we found the high
affinity [3H]-imidacloprid binding site had been lost in
FRC and the remaining lower affinity site was altered,
resulting in a substantial overall reduction in binding
affinity. Recent study of nAChR subunits in the Hemi-
pteran N. lugens has suggested which subunits of the
nAChR contribute to the formation of the imidacloprid
binding site [17]. This work has shown that the Nlb1
subunit is an absolute requirement for imidacloprid
binding and that nAChRs containing Nla1, Nla2 and
Nlb1 constitute the lower affinity site whereas nAChRs
containing Nla3, Nla8 and Nlb1 constitute the higher
affinity site [20]. To see if mutation of the orthologous
nAChR subunits was associated with resistance in FRC
the nucleotide sequence of the N-terminal (agonist
binding) region of six nAChR subunit (Mpa1-5 and
Mpb1) genes from FRC, 4106A and 5191A was com-
pared. No non-synonymous changes were observed
between clones in any nAChR a subunit. However, a
single point mutation in the loop D region of the nAChR
b1 subunit of the FRC clone was identified that causes an
arginine to threonine substitution (R81T). Loop D is one
of three regions of the b1 subunit that in combination
with loops A, B and C of a subunits form the acetylcho-
line binding site [21]. Several lines of experimental evi-
dence indicate that the amino acid at this position within
loop D is a key determinant of neonicotinoid binding to
nAChRs. Insect b1 receptors are highly conserved at this
amino acid position and all insect species characterised
to date have a positively charged arginine at this position
(Table 4). In contrast, vertebrate b subunits rarely have a
positively charged amino acid at this position with the
most common residue being a threonine (Table 4).
Indeed, the high sensitivity of insect nAChRs to neonico-
tinoids is thought to be due to interactions between the
distinctive electronegative pharmacophore (nitro or
cyano group) of these insecticides and conserved residues
upstream of loop B, within loop C of a subunits, and cer-
tain positively charged residues in loop D (such as R81)
of b subunits [12,22,23]. Crystallization of molluscan
ACh-binding proteins, homologous to the amino-term-
inal ligand binding domain of nAChR subunits, has con-
firmed that neonicotinoids bind to nAChRs at the same
site as acetylcholine and that amino acids at the corre-
sponding position to R81 are in close proximal contact
with imidacloprid [24]. The most compelling evidence
that R81T reduces neonicotinoid binding comes from
site-directed mutagenesis and homology modelling stu-
dies of vertebrate and insect recombinant receptors [22].
Substituting the threonine residue in the chicken b2
subunit at position 77 (corresponding to the Mpb1 subu-
nit position 81) with arginine or another basic residue
greatly enhanced the affinity of recombinant nAChRs
(such as Drosophila melanogaster Da2/chicken b2
hybrids) for imidacloprid. However, this effect was only
seen following an additional substitution of a nearby resi-
due in the chicken b2 subunit (E79V) to mimic insect b1
subunits which, in contrast to vertebrate b subunits, have
a valine at this position. Models of the recombinant
receptors indicated that the nitro group of imidacloprid
interacts directly with the introduced basic residue at this
position [22]. Interestingly, and importantly, the T77R
substitution did not significantly affect the binding affi-
nity of the natural agonist acetylcholine. The mutation
described in this study therefore appears to confer a ‘ver-
tebrate-like’ quality to the b1 subunit of resistant aphids
resulting in reduced sensitivity of the nAChR to neonico-
tinoids through the loss of direct electrostatic interac-
tions of the electronegative pharmacophore with the
basic arginine residue at this key position within loop D.
The discovery of the mutation at a predicted resistance
‘hotspot’ [22] and its association with the reduced affinity
of the nAChR for imidacloprid also provides further vali-
dation of existing models of neonicotinoid binding and
selectivity for insect nAChRs.
In a recent study of neonicotinoid resistant housefly,
Musca domestica reduced expression of a nAChR alpha
subunit (Mda2) was correlated with the resistance pheno-
type [25]. Given that radioligand binding assays revealed
significant changes to the nature of imidacloprid binding
in the FRC strain it would be interesting, in future, to
investigate if changes in the expression of different nAChR
subunit genes are also associated with resistance.
The relative role of the two mechanisms (P450-mediated
detoxification and target-site insensitivity) in determining
the resistance phenotype warrants further study. In parti-
cular, the potency and dominance characteristics of target-
site resistance alone, and the practical impact of different
combinations of mechanisms on the efficacy of foliar and
systemic applications of neonicotinoids remain to be
investigated. It is possible that target-site resistance has
evolved in a genetic background of enhanced P450 pro-
duction and that the mechanisms act synergistically to
confer unprecedented levels of resistance to neonicoti-
noids in M. persicae.
Conclusions
In summary, we describe, for the first time, a clone of
M. persicae exhibiting control-compromising levels of
resistance to neonicotinoid insecticides. We demonstrate
that resistance is associated with enhanced imidacloprid
metabolism and over-expression of cytochrome P450s but
that additional major mechanisms based on reduced affi-
nity of the target-site to the neonicotinoid imidacloprid
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are involved. We provide strong evidence that resistance is
conferred, in part, through mutation of a key residue in
the loop D region of a nAChR b1 subunit and this repre-
sents the first example of field-evolved target-site resis-
tance to neonicotinoid insecticides.
Methods
Aphid Clones
All aphid lines used in this study were clonal lineages
derived from a single founding female. 4106A was an
insecticide-susceptible clone originating from potatoes
in Scotland in 2000. Clone 5191A originated from
tobacco in Greece in 2007, and exhibited 20-40 fold
resistance to neonicotinoids [6,7]. Clone FRC was
derived from a sample collected from peach orchards in
Southern France in 2009, following reports of reduced
control with neonicotinoids. All clones were reared on
Chinese cabbage under standardised conditions [7].
Insecticide Bioassays
Two bioassay methods were used to establish the extent
of neonicotinoid resistance in the FRC clone using insec-
ticide alone and 5 h after pre-treatment with PBO to
investigate the potential contribution to resistance of
detoxifying enzymes that are inhibited by this synergist
[6]. The ‘micro-application’ bioassay involved dosing
individual aphids on the dorsal surface with 0.25 μl of
acetone plus insecticide using a micro-applicator (Bur-
khard) and measuring mortality 72 h later as previously
described [7]. The ‘spray application’ bioassay involved
spraying insecticide onto aphids and foliage inside a Pot-
ter-Precision laboratory spray tower (Burkhard) [26] For
this formulated imidacloprid (Confidor 200 g/L SL Bayer
S.A. Division Agro, France) and thiamethoxam (Actara
25WG Syngenta Crop Protection AG, Basel, Switzerland)
was used. For synergism assays piperonyl butoxide was
formulated by Syngenta chemists as an 80% EC and
applied in 0.01% non-ionic surfactant, Extravon (Syn-
genta Crop Protection AG, Basel, Switzerland). Test pots
(45 mm diameter) were prepared with discs of Chinese
cabbage on tap water agar. Twenty to thirty mixed age
aphids were transferred to the dishes and allowed to set-
tle for 24 h at 21°C with a 16:8 h light regime. Serial dilu-
tions of insecticide were applied in 3 ml of solution at 0.6
bar with 3 second settling time (equivalent to approxi-
mately 400L/ha). Three replicates were used for each
concentration tested and the responses were assessed
after 72 h. Aphids that were dead or seriously affected
were classed as ‘dead’ and LC50 values were calculated by
LOGIT analysis using Syngenta software.
Imidacloprid Metabolism Assay
Imidacloprid metabolism assays were carried out to
determine which imidacloprid metabolites were observed
in aphids and whether increased metabolism was contri-
buting to resistance in the FRC clone. In both experi-
ments, individual aphids of the 4106A and FRC clones
were treated by topical application of imidacloprid
(0.2 μL, 1 mg/L, corresponding to the LC50 value for
4106A) using a micro-applicator as described in [7].
Owing to the physical constraints of performing topical
applications to aphids, aphids were treated in batches,
which resulted in a 15 minute gap between the first and
last aphid being treated from each batch.
To determine which metabolites were observed in
aphids, ~500 treated aphids of each clone were collected
at 0, 1, 4 and 24 h after treatment, weighed and frozen at
-20°C. Due to the low treatment rate and volume used in
this study, 500 aphids were pooled to provide one sample
for each time point. To remove surface imidacloprid,
aphid samples were washed in acetonitrile (3 × 1 mL),
after which, aphid samples were placed in extraction
tubes (Precellys 24, 0.5 mL, Lysing matrix VK05; Bertin
Technologies, France) containing acetonitrile (0.5 mL).
Samples were macerated for 5 × 20 s using a FastPrep®
FP120 (QBiogene, UK), centrifuged (5590g, 15 min) and
the resulting supernatant was transferred into HPLC vials
for LC-MS/MS analysis. Separation was achieved with a
Accela UPLC pump (Thermo Scientific, UK) using a Phe-
nomoenex Luna (C18, 5 μm, 4.60 × 250 mm) analytical
column, with a mobile phase consisting of water (+0.2 %
formic acid), and a flow rate of 0.8 mL/min. The gradient
elution conditions of acetonitrile:water were as follows:
0 min 10:90, 15 min 47.5:52.5, 15.1 min 80:20, 22 min
80:20, 22.1 min 10:90. The mass spectrometer used was a
TSQ Vantage (Thermo Scientific) equipped with a H-ESI
II source operating in positive ion mode. Analytes were
detected simultaneously using selected-reaction-monitor-
ing (SRM). SRM transitions are outlined in Additional
file 1. Scan time was 0.1 s/transition and the collision gas
pressure was 1.5 mTorr. As noted in Additional file 1,
several metabolites were available as authentic standards.
For these metabolites, extraction efficiencies were deter-
mined, by spiking untreated aphid samples with a known
amount (0.05 μg) prior to performing the maceration and
centrifugation steps, which were between 87-94%. For
4/5-hydroxy-imidacloprid, only 5-hydroxy-imidacloprid
was available as an authentic standard and it was thought
to be unlikely that chromatographic separation of the 4-
and 5-hydroxy metabolites would have been achieved.
Where no authentic standards were available, confirma-
tion was made by comparison of relative retention times
to previous studies [27].
In the second experiment, aphids were treated as
described above, with the following modifications: 250
treated aphids of each clone were collected at 0, 4 and
24 h after treatment, weighed and frozen at -20°C.
Treatments were replicated three times. Aphid samples
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were washed in acetonitrile (3 × 0.5 mL), placed in
extraction tubes (Precellys 24, 0.5 mL, Lysing matrix
VK05) containing acetonitrile (0.25 mL) and prepared as
described above. Recoveries of imidacloprid and 4/5-
hydroxy metabolite were determined using LC-MS/MS.
Separation was achieved using Ultra Performance LC®
(ACQUITY UPLC-System; Waters, UK) using an
ACQUITY UPLC column (HSS T3, 1.8 μm, 100 × 2.1
mm), with a mobile phase consisting of water (+0.2%
formic acid), with a flow rate of 0.6 mL/min. The gradi-
ent elution conditions of acetonitrile:water were as fol-
lows: 0 min 0:100, 0.5 min 0:100, 3.5 min 95:5, 4.5 min
95:5, 4.6 min 0:100, 5.0 min 0:100. The mass spectro-
meter used was a Finnigan TSQ Quantum Discovery
(Thermo Scientific) equipped with an Ion Max source
operating in positive ion mode. Imidacloprid and 4/5-
hydroxy metabolite were detected simultaneously using
SRM.
Microarray
The microarray (Agilent Technologies) used in this
study was designed by the Georg Jander Lab and is
based on a previously described array containing probes
for > 10, 000 M. persicae unigenes produced by Sanger
sequencing [28] augmented with an additional 30, 517
probe set designed on EST unigene sequences identified
in a 454 sequencing project [29]. Microarray experi-
ments consisted of four biological replicates and for
each of these, two hybridisations were done in which
the Cy3 and Cy5 labels were swapped between samples
for a total of eight hybridisations between resistant and
susceptible clones. Arrays were processed, scanned and
the raw data normalised as described previously [7]. The
TM4 suite of software from the Institute of Genomic
Research was used for statistical analysis using the SAM
(Significance Analysis of Microarrays) module and
applying a False Discovery Rate (FDR) of zero to detect
significantly differentially expressed genes [30]. Genes
identified by SAM and showing a transcription ratio > 2
fold in either direction were considered to be differen-
tially transcribed between the two clones. Microarray
data were submitted to the Gene Expression Omnibus
(GEO) database (series no. GSE24629).
Quantitative RT-PCR
Quantitative RT-PCR was used to validate microarray
data by examining the expression profile of selected
genes. Primers were designed to amplify a fragment 90-
150bp in size and are listed in Additional file 4. PCR
reactions were carried out as described previously [7].
Data were analysed using the geometric mean of three
selected housekeeping genes (actin, para which encodes
the voltage gated sodium channel, and ace, which
encodes acetylcholinesterase) for normalisation according
to the strategy described previously [31]. Quantitative
PCR was used to determine CYP6CY3 gene copy number
using genomic DNA as the template as described
previously [7].
Membrane preparation and [3H] imidacloprid binding
Membranes from resistant (FRC) and susceptible
(4106A) aphid clones were prepared and radioligand
binding experiments performed based on previously
described methods [17] with the following modifications.
Aphids, (~5 g) were homogenized on ice in 16 ml of
pre-chilled homogenisation buffer (0.05 M Tris base, pH
7.4 with HCl, 200 μM PMSF) with a motor-driven Ultra
Turrax (5 × 20 sec bursts, level 4.5). The homogenate
was centrifuged (3,000 g, 30 mins at 4°C) and resulting
supernatant filtered through two layers of pre-wetted
mira cloth before a final centrifugation (83,000 g,
60 mins at 4°C). The pellet (crude membrane) was re-
suspended in chilled freshly prepared binding buffer
(0.05 M Tris, 0.12 M NaCl, 100 μM EDTA, pH7.4 HCl),
beaded into liquid N2 and stored at -80°C. The protein
concentration was determined by Bradford assay using
BSA as a standard. Comparative saturation isotherms
were performed in side-by-side fashion with appropriate
time delay. [3H]-imidacloprid (1.1 TBq/mmol, purity >
95%, in-house synthesis) and methyllycaconitine (MLA,
Sigma) (non-specific ligand) were prepared in binding
buffer. Crude aphid membranes were defrosted on ice
and diluted to 5 mg/ml in binding buffer containing
0.2% BSA. Incubations were carried out in a final
volume of 1 ml to avoid ligand depletion at very low
concentrations of added [3H]-imidacloprid (returned
bound counts were in all cases less than 10% of added).
Order of addition was binding buffer, 100 nM MLA or
control, 100 μg membranes followed by [3H]-imidaclo-
prid at indicated concentrations. Reactions equilibrated
over 90 mins at room temperature with constant shak-
ing and were terminated by filtration using a Brandel
harvester onto Whatman GF/B filters pre-soaked in cold
binding buffer with 0.25% polyethylenimine (no BSA).
Filters were rapidly rinsed in a two wash cycle (3 ml)
with ice cold binding buffer (no BSA), removed, allowed
to air-dry for 12 hrs and soaked (6 hrs) in 10 ml scintil-
lant (Scintsafe Gel, Fisher) prior to counting.
Sequence analysis of M. persicae nAChR subunits
Total RNA was isolated from three pools of five adult
aphids from all clones listed above and first strand cDNA
synthesised as described previously [7]. PCR amplification
was performed using gene-specific oligonucleotide primers
designed to the published nAChRa1 (X81887), nAChRa2
(X81888), nAChRa3 (AJ236786), nAChRa4 (AJ236787),
nAChRa5 (AJ880084) and nAChRb1 (AJ251838) as
described previously [7]. Amplicons of the expected size
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were ethanol precipitated and sequenced directly in both
directions using the BigDye mix (Applied Biosystems).
Additional material
Additional file 1: Selected-Reaction-Monitoring transitions for
selected imidacloprid metabolites. Molecular weight, SRM transitions,
collision energies and availability of authentic standards are detailed for
11 imidacloprid metabolites.
Additional file 2: ESTs identified by microarray analysis significantly
differentially transcribed between the insecticide resistant M.
persicae clone FRC and the susceptible clone 4106A. The full list of
ESTs along with Log2, calculated fold-change values and a description
based on the closest BLAST hit is detailed.
Additional file 3: Fold change in expression of CYP6CY3 and
additional P450 genes in the M. persicae clones FRC and 5191A
(compared to the susceptible reference clone 4106A) as determined
by quantitative PCR. For each EST the most similar Acyrthosiphon pisum
P450 gene is detailed.
Additional file 4: Sequences of primers used in this study. Primer
sequences are listed along with the purpose for which they were used.
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